Counterfeiting, Compliance, and Controls

FDA and manufacturers seek to curb drug counterfeiting while legislators consider liberalizing drug importing policies to cut pharmaceutical costs.

Related Content:

Regulatory WatchSupply ChainAnticounterfeiting, Track and Trace SystemsPharmaceutical Technology-09-02-2003

European Medicines Regulatory Network on Track to Meet Goals

A Record Year for Disease Elimination

List of Critical Medicines Published in EU